COMPARISON OF THE EFFECTS OF PIRMENOL AND LIDOCAINE ON INTRAVENTRICULAR-CONDUCTION IN CANINE MYOCARDIAL-INFARCTION

被引:2
|
作者
HASHIMOTO, H [1 ]
OZAKI, T [1 ]
NAGASHIMA, S [1 ]
NAKASHIMA, M [1 ]
机构
[1] HAMAMATSU UNIV SCH MED, DEPT PHARMACOL, HAMAMATSU, SHIZUOKA 431-31, JAPAN
关键词
PIRMENOL; LIDOCAINE; MYOCARDIAL INFARCTION; INTRAVENTRICULAR CONDUCTION; INTERVAL DEPENDENCY;
D O I
10.1016/0022-0736(91)90020-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effects of pirmenol hydrochloride and lidocaine hydrochloride on intraventricular conduction were examined in the infarcted heart of anesthetized dogs. The effects of the drugs on the excitation induced by ventricular stimulations were determined with coupling intervals between 150 and 1,000 ms. Effects of the drugs on the His bundle electrocardiograms were also examined. Pirmenol in doses of 1-5 mg/kg prolonged the conduction time in the infarcted zones over a wide range of coupling intervals. Pirmenol at 5 mg/kg blocked the delayed conduction at a short coupling interval in the infarcted zones. The effect of pirmenol on the conduction time in the normal zone was slight. Lidocaine in doses of 3 and 10 mg/kg prolonged the conduction time in the infarcted zone at a short coupling interval. Pirmenol did not significantly prolong PQ or AH interval. In conclusion, pirmenol selectively depressed the delayed conduction in the infarcted zone, which could result in a reentrant pathway. The effect of pirmenol on delayed conduction was dependent on the coupling interval and was quite different from that of lidocaine.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [31] MYOCARDIAL-INFARCTION AND INTRAVENTRICULAR-CONDUCTION TRANSFER ASSOCIATED WITH HIGH-GRADE AV BLOCKAGE - EVOLUTION OF DEFINITIVE PACEMAKERS
    ARRIAGADA, D
    FAJURI, A
    DUBERNET, J
    GONZALEZ, R
    CORBALAN, R
    RODRIGUEZ, JA
    REVISTA MEDICA DE CHILE, 1985, 113 (05) : 22 - 22
  • [32] EFFECT OF CLASS-I ANTIARRHYTHMIC DRUGS ON INTRAVENTRICULAR-CONDUCTION AND ITS CYCLE LENGTH DEPENDENCY IN MYOCARDIAL-INFARCTION OF DOGS
    HASHIMOTO, H
    SATO, N
    MIYAZAWA, K
    MIZUNO, A
    TAKIGUCHI, Y
    NAKASHIMA, M
    FOLIA PHARMACOLOGICA JAPONICA, 1986, 87 (06) : P65 - P66
  • [33] EFFECTS OF ISOPROTERENOL ON ABNORMAL INTRAVENTRICULAR-CONDUCTION
    HALPERN, MS
    CHIALE, PA
    NAU, GJ
    PRZYBYLSKI, J
    LAZZARI, JO
    ELIZARI, MV
    ROSENBAUM, MB
    CIRCULATION, 1980, 62 (06) : 1357 - 1364
  • [34] LONG-TERM PROGNOSTIC-SIGNIFICANCE AND ELECTROPHYSIOLOGICAL EVOLUTION OF INTRAVENTRICULAR-CONDUCTION DISTURBANCES COMPLICATING ACUTE MYOCARDIAL-INFARCTION
    PAGNONI, F
    FINZI, A
    VALENTINI, R
    AMBROSINI, F
    LOTTO, A
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (01): : 91 - 100
  • [35] INCIDENCE AND MORTALITY OF INTRAVENTRICULAR CONDUCTION DEFECTS IN ACUTE MYOCARDIAL-INFARCTION
    COL, JJ
    WEINBERG, SL
    AMERICAN JOURNAL OF CARDIOLOGY, 1972, 29 (03): : 344 - &
  • [36] LIDOCAINE IN MYOCARDIAL-INFARCTION
    DAVIS, LJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (05): : 275 - 275
  • [37] HEMODYNAMIC EFFECTS OF PROCAINAMIDE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION AND COMPARISON WITH LIDOCAINE
    MILLER, RR
    HILLIARD, G
    LIES, JE
    MASSUMI, RA
    ZELIS, R
    MASON, DT
    AMSTERDA.EA
    AMERICAN JOURNAL OF MEDICINE, 1973, 55 (02): : 161 - 168
  • [38] EFFECT OF LIDOCAINE ON INTRAVENTRICULAR-CONDUCTION IN DOG HEART AT VARIOUS K LEVELS
    SAITO, S
    CHEN, CM
    GETTES, LS
    CIRCULATION, 1975, 52 (04) : 85 - 85
  • [39] EFFECTS OF AJMALINES ON ATRIOVENTRICULAR AND INTRAVENTRICULAR-CONDUCTION IN DOG
    JAILLON, P
    MOUILLE, P
    CHEYMOL, G
    HECKLE, J
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1976, 224 (02): : 310 - 324
  • [40] EFFECTS OF IMIPRAMINE AND AMITRIPTYLINE ON INTRAVENTRICULAR-CONDUCTION, EFFECTIVE REFRACTORY PERIOD, INCIDENCE OF VENTRICULAR ARRHYTHMIAS INDUCED BY PROGRAMMED STIMULATION, AND ON ELECTROCARDIOGRAM AFTER MYOCARDIAL-INFARCTION IN DOG
    NISHIMOTO, M
    HASHIMOTO, H
    OZAKI, T
    TAGUCHI, T
    OHARA, K
    NAKASHIMA, M
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1994, 328 (01): : 39 - 53